Treatment-induced sculpting of melanoma phenotype and immunogenicity – Impact on resistance to CD8 T cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Duisburg, Essen, Universität Duisburg-Essen, Dissertation, 2022
- Keyword
-
Krebs
Melanom
Immuntherapie
Hautkrebs
- Event
-
Veröffentlichung
- (where)
-
Duisburg, Essen
- (who)
-
Universität Duisburg-Essen
- (when)
-
2022
- Creator
- Contributor
- DOI
-
10.17185/duepublico/77123
- URN
-
urn:nbn:de:hbz:465-20221125-104851-5
- Rights
-
Open Access unbekannt; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Thier, Beatrice
- Paschen, Annette
- Universität Duisburg-Essen
Time of origin
- 2022
Other Objects (12)
Nuclear AREG affects a low‐proliferative phenotype and contributes to drug resistance of melanoma
Cytokine resistance in melanoma
Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells
Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade
ROR2, a driver of “phenotype switching” in melanoma?
CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma
Role of signal transduction and microRNAs on the immunogenicity of melanoma cells
Mechanisms and immunogenicity of nsPEF-induced cell death in B16F10 melanoma tumors
Immunogenicity of the HO-1 peptide eluted from renal cell carcinoma for CD8 T cells
Immunogenicity of the HO-1 peptide eluted from renal cell carcinoma for CD8 T cells
Biophysical characterization of melanoma cell phenotype markers during metastatic progression
Nuclear AREG affects a low‐proliferative phenotype and contributes to drug resistance of melanoma
Cytokine resistance in melanoma
Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells
Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade
ROR2, a driver of “phenotype switching” in melanoma?
CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma
Role of signal transduction and microRNAs on the immunogenicity of melanoma cells
Mechanisms and immunogenicity of nsPEF-induced cell death in B16F10 melanoma tumors
Immunogenicity of the HO-1 peptide eluted from renal cell carcinoma for CD8 T cells
Immunogenicity of the HO-1 peptide eluted from renal cell carcinoma for CD8 T cells
Biophysical characterization of melanoma cell phenotype markers during metastatic progression
Nuclear AREG affects a low‐proliferative phenotype and contributes to drug resistance of melanoma
Cytokine resistance in melanoma
Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells
Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade
ROR2, a driver of “phenotype switching” in melanoma?
CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma
Role of signal transduction and microRNAs on the immunogenicity of melanoma cells
Mechanisms and immunogenicity of nsPEF-induced cell death in B16F10 melanoma tumors
Immunogenicity of the HO-1 peptide eluted from renal cell carcinoma for CD8 T cells
Immunogenicity of the HO-1 peptide eluted from renal cell carcinoma for CD8 T cells